Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints... see more

Recent & Breaking News (NDAQ:APHA)

Aphria receives conditional approval to graduate to the TSX

MarketWire Canada February 6, 2017

Aphria Inc. Announces $50 Million Bought Deal

MarketWire Canada February 6, 2017

Canada’s Prince and Princess of pot

Jeff Nielson February 3, 2017

Cannabis Industry's $1.2 Billion Investments: Viridian Looks Back On 2016's Marijuana Deals, M&A

Benzinga.com  January 18, 2017

Popularity of Cannabis Products Increases in North America

PR Newswire January 18, 2017

Aphria's Vision to be Reality - Part IV expansion project to increase greenhouse growing space to 1 million square feet

MarketWire Canada January 16, 2017

Aphria Reports 19% Growth in Quarterly Revenue

MarketWire Canada January 11, 2017

Aphria comments on today's Globe and Mail story on pesticide use and reaffirms its commitment to quality and safety

MarketWire Canada December 29, 2016

Aphria Announces Final Approval of Copperstate transaction

MarketWire Canada December 21, 2016

Aphria continues expansion strategy

MarketWire Canada December 14, 2016

Legal Marijuana Growing Technologies Allowing Canadian Companies to Capitalize on Exploding Cannabis Industry

PR Newswire December 8, 2016

Aphria Makes $1,000,000 Investment in Tetra Bio-Pharma via Private Placement to Fund PhytoPain Pharma Clinical Trials

MarketWire Canada December 6, 2016

Rising Demand From Cannabis Recreational and Medicinal Users Fueling Canadian Marijuana Market

PR Newswire Europe Non Regulatory December 5, 2016

Aphria Announces Closing of Bought Deal Financing

MarketWire Canada November 30, 2016

ArcView CEO Troy Dayton Shares Optimistic Outlook For The Marijuana Industry Under Trump

Benzinga.com  November 29, 2016

IIROC Trading Resumption - APH

Canada NewsWire November 24, 2016

IIROC Trading Halt - APH

Canada NewsWire November 24, 2016

CORRECTION - Aphria agrees with changes to Veteran Affairs policy

MarketWire Canada November 24, 2016

Aphria agrees with changes to Veteran Affairs policy

MarketWire Canada November 24, 2016

Legal Cannabis Market Expected to Grow

PR Newswire November 23, 2016